Ovarian follicle populations of the rat express TGF-β signalling pathways

Molecular and Cellular Endocrinology

Volumn 202, Issue 1-2, 2003, Pages 53-57

  Drummond, Ann E ^a   Dyson, Mitzi ^a   Tan Le, Minh ^a   Ethier, Jean Francois ^a   Findlay, Jock K ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Activin; Betaglycan; Ovary; Receptor; Smad; Transforming growth factor

Indexed keywords

ACTIVIN; ACTIVIN RECEPTOR 1; ACTIVIN RECEPTOR 2; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR; GROWTH DIFFERENTIATION FACTOR 9; PROTEIN SERINE THREONINE KINASE; RECEPTOR PROTEIN; RECEPTOR SUBTYPE; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

CELL FUNCTION; CONFERENCE PAPER; INSECT; NEMATODE; NONHUMAN; OVARY FOLLICLE; OVARY FUNCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VERTEBRATE;

EID: 0038627535     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(03)00062-5     Document Type: Conference Paper

References (61)

1. Aaltonen J., Laitinen M.P., Vuojolainen K., Jaatinen R., Horelli-Kuitunen N., Seppa L., Louhio H., Tuuri T., Sjoberg J., Butzow R., Hovata O., Dale L., Ritvos O. Human growth differentiation factor 9 (GDF-9) and its novel homolog GDF-9B are expressed in oocytes during early folliculogenesis. J. Clin. Endocrinol. Metab. 84:1999;2744-2750.
2. Attisano L., Wrana J.L., Cheifetz S., Massague J. Novel activin receptors: distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors. Cell. 68:1992;97-108.
3. Baarends W.M., Uilenbroek J.T., Kramer P., Hoogerbrugge J.W., van Leeuwen E.C., Themmen A.P., Grootegoed J.A. Anti-mullerian hormone and anti-mullerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology. 136:1995;4951-4962.
4. Baarends W.M., van Helmond M.J., Post M., van der Schoot P.J., Hoogerbrugge J.W., de Winter J.P., Uilenbroek J.T., Karels B., Wilming L.G., Meijers J.H., et al. A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the mullerian duct. Development. 120:1994;189-197.
5. Baker J.C., Harland R.M. A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway. Genes Dev. 10:1996;1880-1889.
6. Bicsak T.A., Cajander S.B., Vale W., Hsueh A.J. Inhibin: studies of stored and secreted forms by biosynthetic labeling and immunodetection in cultured rat granulosa cells. Endocrinology. 122:1988;741-748.
7. Chegini N., Flanders K.C. Presence of transforming growth factor-beta and their selective cellular localization in human ovarian tissue of various reproductive stages. Endocrinology. 130:1992;1707-1715.
8. Clarke T.R., Hoshiya Y., Yi S.E., Liu X., Lyons K.M., Donahoe P.K. Mullerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression. Mol. Endocrinol. 15:2001;946-959.
9. di Clemente N., Wilson C., Faure E., Boussin L., Carmillo P., Tizard R., Picard J.Y., Vigier B., Josso N., Cate R. Cloning, expression, and alternative splicing of the receptor for anti-Mullerian hormone. Mol. Endocrinol. 8:1994;1006-1020.
10. Dong J., Albertini D.F., Nishimori K., Kumar T.R., Lu N., Matzuk M.M. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature. 383:1996;531-535.
11. Drummond A.E., Dyson M., Mercer J.E., Findlay J.K. Differential responses of post-natal rat ovarian cells to FSH and activin. Mol. Cell. Endocrinol. 122:1996;21-32.
12. Drummond A.E., Dyson M., Thean E., Groome N.P., Robertson D.M., Findlay J.K. Temporal and hormonal regulation of inhibin protein and subunit mRNA expression by post-natal and immature rat ovaries. J. Endocrinol. 166:2000;339-354.
13. Drummond A.E., Le M.T., Ethier J.F., Dyson M., Findlay J.K. Expression and localization of activin receptors, Smads, and beta glycan to the postnatal rat ovary. Endocrinology. 143:2002;1423-1433.
14. Dube J.L., Wang P., Elvin J., Lyons K.M., Celeste A.J., Matzuk M.M. The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes. Mol. Endocrinol. 12:1998;1809-1817.
15. Elvin J.A., Yan C., Matzuk M.M. Oocyte-expressed TGF-beta superfamily members in female fertility. Mol. Cell. Endocrinol. 159:2000;1-5.
16. Ethier J.F., Farnworth P.G., Findlay J.K., Ooi G.T. Transforming growth factor-beta modulates inhibin-A bioactivity in the Lbeta T2 gonadotrope cell line by competing for binding to betaglycan. Molec. Endocrinol. 16:2002;2754-2763.
17. Feng Z.M., Madigan M.B., Chen C.L. Expression of type II activin receptor genes in the male and female reproductive tissues of the rat. Endocrinology. 132:1993;2593-2600.
18. Findlay J.K. An update on the roles of inhibin, activin, and follistatin as local regulators of folliculogenesis. Biol. Reprod. 48:1993;15-23.
19. Findlay J.K., Drummond A.E., Dyson M., Baillie A.J., Robertson D.M., Ethier J. Production and actions of inhibin and activin during folliculogenesis in the rat. Mol. Cell. Endocrinol. 180:2001;139-144.
20. Graff J.M., Thies R.S., Song J.J., Celeste A.J., Melton D.A. Studies with a Xenopus BMP receptor suggest that ventral mesoderm-inducing signals override dorsal signals in vivo. Cell. 79:1994;169-179.
21. Hata A., Lagna G., Massague J., Hemmati-Brivanlou A. Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev. 12:1998;186-197.
22. Hayashi H., Abdollah S., Qiu Y., Cai J., Xu Y.Y., Grinnell B.W., Richardson M.A., Topper J.N., Gimbrone M.A. Jr., Wrana J.L., Falb D. The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell. 89:1997;1165-1173.
23. He W.W., Gustafson M.L., Hirobe S., Donahoe P.K. Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor-beta type II receptor family. Dev. Dyn. 196:1993;133-142.
24. Hoodless P.A., Wrana J.L. Mechanism and function of signaling by the TGF beta superfamily. Curr. Top. Microbiol. Immunol. 228:1998;235-272.
25. Imamura T., Takase M., Nishihara A., Oeda E., Hanai J., Kawabata M., Miyazono K. Smad6 inhibits signalling by the TGF-beta superfamily. Nature. 389:1997;622-626.
26. Ingraham H.A., Hirokawa Y., Roberts L.M., Mellon S.H., McGee E., Nachtigal M.W., Visser J.A. Autocrine and paracrine Mullerian inhibiting substance hormone signaling in reproduction. Recent Prog. Horm. Res. 55:2000;53-67. discussion 67-68.
27. Josso N., di Clemente N., Gouedard L. Anti-Mullerian hormone and its receptors. Mol. Cell. Endocrinol. 179:2001;25-32.
28. Kano K., Notani A., Nam S.Y., Fujisawa M., Kurohmaru M., Hayashi Y. Cloning and studies of the mouse cDNA encoding Smad3. J. Vet. Med. Sci. 61:1999;213-219.
29. Knight P.G., Glister C. Potential local regulatory functions of inhibins, activins and follistatin in the ovary. Reproduction. 121:2001;503-512.
30. Laitinen M., Vuojolainen K., Jaatinen R., Ketola I., Aaltonen J., Lehtonen E., Heikinheimo M., Ritvos O. A novel growth differentiation factor-9 (GDF-9) related factor is co-expressed with GDF-9 in mouse oocytes during folliculogenesis. Mech. Dev. 78:1998;135-140.
31. Lee W.S., Otsuka F., Moore R.K., Shimasaki S. Effect of bone morphogenetic protein-7 on folliculogenesis and ovulation in the rat. Biol. Reprod. 65:2001;994-999.
32. Lewis K.A., Gray P.C., Blount A.L., MacConell L.A., Wiater E., Bilezikjian L.M., Vale W. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Nature. 404:2000;411-414.
33. Li M., Li J., Hoodless P.A., Tzukazaki T., Wrana J.L., Attisano L., Tsang B.K. Mothers against decapentaplegic-related protein 2 expression in avian granulosa cells is up-regulated by transforming growth factor beta during ovarian follicular development. Endocrinology. 138:1997;3659-3665.
34. MacConell L.A., Leal A.M., Vale W.W. The distribution of betaglycan protein and mRNA in rat brain, pituitary, and gonads: implications for a role for betaglycan in inhibin-mediated reproductive functions. Endocrinology. 143:2002;1066-1075.
35. Macias-Silva M., Hoodless P.A., Tang S.J., Buchwald M., Wrana J.L. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2. J. Biol. Chem. 273:1998;25628-25636.
36. Massague J. TGF-beta signal transduction. Annu. Rev. Biochem. 67:1998;753-791.
37. Massague J., Chen Y.G. Controlling TGF-beta signaling. Genes Dev. 14:2000;627-644.
38. Mather J.P., Moore A., Li R.H. Activins, inhibins, and follistatins: further thoughts on a growing family of regulators. Proc. Soc. Exp. Biol. Med. 215:1997;209-222.
39. McGrath S.A., Esquela A.F., Lee S.J. Oocyte-specific expression of growth/differentiation factor-9. Mol. Endocrinol. 9:1995;131-136.
40. Meunier H., Cajander S.B., Roberts V.J., Rivier C., Sawchenko P.E., Hsueh A.J., Vale W. Rapid changes in the expression of inhibin alpha-, beta A-, and beta B-subunits in ovarian cell types during the rat estrous cycle. Mol. Endocrinol. 2:1988;1352-1363.
41. Miyazono K., Kusanagi K., Inoue H. Divergence and convergence of TGF-beta/BMP signaling. J. Cell Physiol. 187:2001;265-276.
42. Osterlund C., Fried G. TGFbeta receptor types I and II and the substrate proteins Smad 2 and 3 are present in human oocytes. Mol. Hum. Reprod. 6:2000;498-503.
43. Otsuka F., Moore R.K., Shimasaki S. Biological function and cellular mechanism of bone morphogenetic protein-6 in the ovary. J. Biol. Chem. 276:2001;32889-32895.
44. Pangas S.A., Rademaker A.W., Fishman D.A., Woodruff T.K. Localization of the activin signal transduction components in normal human ovarian follicles: implications for autocrine and paracrine signaling in the ovary. J. Clin. Endocrinol. Metab. 87:2002;2644-2657.
45. Piek E., Heldin C.H., ten Dijke P. Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J. 13:1999;2105-2124.
46. Schwall R.H., Mason A.J., Wilcox J.N., Bassett S.G., Zeleznik A.J. Localization of inhibin/activin subunit mRNAs within the primate ovary. Mol. Endocrinol. 4:1990;75-79.
47. Shimasaki S., Zachow R.J., Li D., Kim H., Iemura S., Ueno N., Sampath K., Chang R.J., Erickson G.F. A functional bone morphogenetic protein system in the ovary. Proc. Natl. Acad. Sci. USA. 96:1999;7282-7287.
48. Sidis Y., Fujiwara T., Leykin L., Isaacson K., Toth T., Schneyer A.L. Characterization of inhibin/activin subunit, activin receptor, and follistatin messenger ribonucleic acid in human and mouse oocytes: evidence for activin's paracrine signaling from granulosa cells to oocytes. Biol. Reprod. 59:1998;807-812.
49. Skinner M.K., Keski-Oja J., Osteen K.G., Moses H.L. Ovarian thecal cells produce transforming growth factor-beta which can regulate granulosa cell growth. Endocrinology. 121:1987;786-792.
50. Teixeira J., He W.W., Shah P.C., Morikawa N., Lee M.M., Catlin E.A., Hudson P.L., Wing J., Maclaughlin D.T., Donahoe P.K. Developmental expression of a candidate mullerian inhibiting substance type II receptor. Endocrinology. 137:1996;160-165.
51. ten Dijke P., Yamashita H., Sampath T.K., Reddi A.H., Estevez M., Riddle D.L., Ichijo H., Heldin C.H., Miyazono K. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J. Biol. Chem. 269:1994;16985-16988.
52. Ueno S., Kuroda T., Maclaughlin D.T., Ragin R.C., Manganaro T.F., Donahoe P.K. Mullerian inhibiting substance in the adult rat ovary during various stages of the estrous cycle. Endocrinology. 125:1989;1060-1066.
53. Ueno S., Takahashi M., Manganaro T.F., Ragin R.C., Donahoe P.K. Cellular localization of mullerian inhibiting substance in the developing rat ovary. Endocrinology. 124:1989;1000-1006.
54. Vigier B., Picard J.Y., Tran D., Legeai L., Josso N. Production of anti-Mullerian hormone: another homology between Sertoli and granulosa cells. Endocrinology. 114:1984;1315-1320.
55. Visser J.A., Olaso R., Verhoef-Post M., Kramer P., Themmen A.P., Ingraham H.A. The serine/threonine transmembrane receptor ALK2 mediates Mullerian inhibiting substance signaling. Mol. Endocrinol. 15:2001;936-945.
56. Vitt U.A., Hsueh A.J. Stage-dependent role of growth differentiation factor-9 in ovarian follicle development. Mol. Cell. Endocrinol. 183:2001;171-177.
57. Woodruff T.K., Meunier H., Jones P.B., Hsueh A.J., Mayo K.E. Rat inhibin: molecular cloning of alpha- and beta-subunit complementary deoxyribonucleic acids and expression in the ovary. Mol. Endocrinol. 1:1987;561-568.
58. Wu T.C., Jih M.H., Wang L., Wan Y.J. Expression of activin receptor II and IIB mRNA isoforms in mouse reproductive organs and oocytes. Mol. Reprod. Dev. 38:1994;9-15.
59. Xu J., Oakley J., McGee E.A. Stage-specific expression of smad2 and smad3 during folliculogenesis. Biol. Reprod. 66:2002;1571-1578.
60. Zhang Y., Derynck R. Regulation of Smad signalling by protein associations and signalling crosstalk. Trends Cell. Biol. 9:1999;274-279.
61. Zhu H.J., Burgess A.W. Regulation of transforming growth factor-beta signaling. Mol. Cell Biol. Res. Commun. 4:2001;321-330.